|
||
Articles |



Division of Cell and Gene Therapy, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892; the
Ministry of Agriculture and Forestry (Verification Agency), Te Kuiti, New Zealand; and the ¶ Dairy Science Group, AgResearch, Ruakura, Hamilton, New Zealand
We have analyzed the immune system in Stat5-deficient mice. Although Stat5a–/– splenocytes have a partial defect in anti-CD3-induced proliferation that can be overcome by high dose interleukin (IL)-2, we now demonstrate that defective proliferation in Stat5b–/– splenocytes cannot be corrected by this treatment. Interestingly, this finding may be at least partially explained by diminished expression of the IL-2 receptor β chain (IL-2Rβ), which is a component of the receptors for both IL-2 and IL-15, although other defects may also exist. Similar to the defect in proliferation in activated splenocytes, freshly isolated splenocytes from Stat5b–/– mice exhibited greatly diminished proliferation in response to IL-2 and IL-15. This results from both a decrease in the number and responsiveness of natural killer (NK) cells. Corresponding to the diminished proliferation, basal as well as IL-2– and IL-15–mediated boosting of NK cytolytic activity was also greatly diminished. These data indicate an essential nonredundant role for Stat5b for potent NK cell–mediated proliferation and cytolytic activity.
Key Words: natural killer cells Stat5b Stat5a interleukin 2 interleukin 15
K. Imada was supported in part by a Japanese Society for the Promotion of Science research fellowship for Japanese biomedical and behavioral researchers at NIH and by the Sankyo Foundation of Life Science.
Abbreviations used: STAT, signal transducers and activators of transcription.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| TABLE OF CONTENTS |
|